![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ITPR1 |
Gene summary for ITPR1 |
![]() |
Gene information | Species | Human | Gene symbol | ITPR1 | Gene ID | 3708 |
Gene name | inositol 1,4,5-trisphosphate receptor type 1 | |
Gene Alias | ACV | |
Cytomap | 3p26.1 | |
Gene Type | protein-coding | GO ID | GO:0001666 | UniProtAcc | B4DER3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
3708 | ITPR1 | LZE4T | Human | Esophagus | ESCC | 7.61e-05 | 1.40e-01 | 0.0811 |
3708 | ITPR1 | P2T-E | Human | Esophagus | ESCC | 7.13e-05 | 1.98e-02 | 0.1177 |
3708 | ITPR1 | P4T-E | Human | Esophagus | ESCC | 4.51e-12 | 1.66e-01 | 0.1323 |
3708 | ITPR1 | P5T-E | Human | Esophagus | ESCC | 1.02e-07 | 8.34e-02 | 0.1327 |
3708 | ITPR1 | P9T-E | Human | Esophagus | ESCC | 9.55e-05 | 1.78e-01 | 0.1131 |
3708 | ITPR1 | P11T-E | Human | Esophagus | ESCC | 1.03e-04 | 5.89e-01 | 0.1426 |
3708 | ITPR1 | P15T-E | Human | Esophagus | ESCC | 3.90e-02 | 1.23e-01 | 0.1149 |
3708 | ITPR1 | P16T-E | Human | Esophagus | ESCC | 2.37e-04 | -3.56e-03 | 0.1153 |
3708 | ITPR1 | P21T-E | Human | Esophagus | ESCC | 1.86e-03 | -3.66e-03 | 0.1617 |
3708 | ITPR1 | P23T-E | Human | Esophagus | ESCC | 7.28e-10 | 1.37e-01 | 0.108 |
3708 | ITPR1 | P24T-E | Human | Esophagus | ESCC | 8.40e-03 | 2.93e-02 | 0.1287 |
3708 | ITPR1 | P26T-E | Human | Esophagus | ESCC | 4.01e-08 | 6.80e-02 | 0.1276 |
3708 | ITPR1 | P27T-E | Human | Esophagus | ESCC | 6.35e-08 | 1.57e-01 | 0.1055 |
3708 | ITPR1 | P28T-E | Human | Esophagus | ESCC | 2.68e-08 | 8.87e-02 | 0.1149 |
3708 | ITPR1 | P32T-E | Human | Esophagus | ESCC | 1.96e-19 | 5.74e-01 | 0.1666 |
3708 | ITPR1 | P37T-E | Human | Esophagus | ESCC | 1.29e-11 | 2.22e-01 | 0.1371 |
3708 | ITPR1 | P40T-E | Human | Esophagus | ESCC | 5.89e-03 | 8.91e-02 | 0.109 |
3708 | ITPR1 | P42T-E | Human | Esophagus | ESCC | 1.68e-02 | 8.06e-02 | 0.1175 |
3708 | ITPR1 | P49T-E | Human | Esophagus | ESCC | 2.45e-02 | 3.42e-01 | 0.1768 |
3708 | ITPR1 | P52T-E | Human | Esophagus | ESCC | 2.71e-04 | 4.86e-03 | 0.1555 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0097193111 | Esophagus | ESCC | intrinsic apoptotic signaling pathway | 222/8552 | 288/18723 | 5.87e-28 | 2.02e-25 | 222 |
GO:0034976111 | Esophagus | ESCC | response to endoplasmic reticulum stress | 192/8552 | 256/18723 | 7.15e-22 | 1.30e-19 | 192 |
GO:001050617 | Esophagus | ESCC | regulation of autophagy | 220/8552 | 317/18723 | 6.72e-18 | 6.36e-16 | 220 |
GO:0070482111 | Esophagus | ESCC | response to oxygen levels | 218/8552 | 347/18723 | 6.91e-11 | 2.17e-09 | 218 |
GO:0036293111 | Esophagus | ESCC | response to decreased oxygen levels | 201/8552 | 322/18723 | 8.37e-10 | 2.04e-08 | 201 |
GO:0001666111 | Esophagus | ESCC | response to hypoxia | 192/8552 | 307/18723 | 1.59e-09 | 3.69e-08 | 192 |
GO:0051235110 | Esophagus | ESCC | maintenance of location | 200/8552 | 327/18723 | 1.01e-08 | 2.02e-07 | 200 |
GO:0070059111 | Esophagus | ESCC | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 50/8552 | 63/18723 | 4.37e-08 | 7.96e-07 | 50 |
GO:00097919 | Esophagus | ESCC | post-embryonic development | 56/8552 | 80/18723 | 9.08e-06 | 8.71e-05 | 56 |
GO:0051651111 | Esophagus | ESCC | maintenance of location in cell | 126/8552 | 214/18723 | 6.57e-05 | 5.00e-04 | 126 |
GO:0032469110 | Esophagus | ESCC | endoplasmic reticulum calcium ion homeostasis | 21/8552 | 25/18723 | 9.12e-05 | 6.54e-04 | 21 |
GO:009719330 | Thyroid | HT | intrinsic apoptotic signaling pathway | 52/1272 | 288/18723 | 7.65e-11 | 1.06e-08 | 52 |
GO:003497627 | Thyroid | HT | response to endoplasmic reticulum stress | 41/1272 | 256/18723 | 2.43e-07 | 1.20e-05 | 41 |
GO:007048227 | Thyroid | HT | response to oxygen levels | 50/1272 | 347/18723 | 3.61e-07 | 1.65e-05 | 50 |
GO:003629327 | Thyroid | HT | response to decreased oxygen levels | 46/1272 | 322/18723 | 1.34e-06 | 5.14e-05 | 46 |
GO:000166627 | Thyroid | HT | response to hypoxia | 44/1272 | 307/18723 | 2.07e-06 | 7.53e-05 | 44 |
GO:003246924 | Thyroid | HT | endoplasmic reticulum calcium ion homeostasis | 7/1272 | 25/18723 | 1.07e-03 | 1.07e-02 | 7 |
GO:005165129 | Thyroid | HT | maintenance of location in cell | 27/1272 | 214/18723 | 1.39e-03 | 1.32e-02 | 27 |
GO:001050620 | Thyroid | HT | regulation of autophagy | 35/1272 | 317/18723 | 3.15e-03 | 2.52e-02 | 35 |
GO:005123528 | Thyroid | HT | maintenance of location | 35/1272 | 327/18723 | 5.16e-03 | 3.47e-02 | 35 |
Page: 1 2 3 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa05016210 | Esophagus | ESCC | Huntington disease | 226/4205 | 306/8465 | 1.38e-18 | 8.72e-17 | 4.46e-17 | 226 |
hsa05012211 | Esophagus | ESCC | Parkinson disease | 201/4205 | 266/8465 | 1.56e-18 | 8.72e-17 | 4.46e-17 | 201 |
hsa05022210 | Esophagus | ESCC | Pathways of neurodegeneration - multiple diseases | 318/4205 | 476/8465 | 6.10e-15 | 2.04e-13 | 1.05e-13 | 318 |
hsa05010210 | Esophagus | ESCC | Alzheimer disease | 263/4205 | 384/8465 | 1.80e-14 | 5.47e-13 | 2.80e-13 | 263 |
hsa05020210 | Esophagus | ESCC | Prion disease | 193/4205 | 273/8465 | 6.42e-13 | 1.34e-11 | 6.89e-12 | 193 |
hsa05131211 | Esophagus | ESCC | Shigellosis | 176/4205 | 247/8465 | 2.27e-12 | 4.01e-11 | 2.05e-11 | 176 |
hsa0421829 | Esophagus | ESCC | Cellular senescence | 119/4205 | 156/8465 | 5.89e-12 | 9.40e-11 | 4.81e-11 | 119 |
hsa0421027 | Esophagus | ESCC | Apoptosis | 102/4205 | 136/8465 | 1.05e-09 | 1.21e-08 | 6.21e-09 | 102 |
hsa05170210 | Esophagus | ESCC | Human immunodeficiency virus 1 infection | 147/4205 | 212/8465 | 3.37e-09 | 3.53e-08 | 1.81e-08 | 147 |
hsa05167211 | Esophagus | ESCC | Kaposi sarcoma-associated herpesvirus infection | 136/4205 | 194/8465 | 4.28e-09 | 4.22e-08 | 2.16e-08 | 136 |
hsa0414010 | Esophagus | ESCC | Autophagy - animal | 101/4205 | 141/8465 | 7.60e-08 | 6.21e-07 | 3.18e-07 | 101 |
hsa0520529 | Esophagus | ESCC | Proteoglycans in cancer | 138/4205 | 205/8465 | 1.79e-07 | 1.40e-06 | 7.15e-07 | 138 |
hsa05417211 | Esophagus | ESCC | Lipid and atherosclerosis | 143/4205 | 215/8465 | 3.30e-07 | 2.45e-06 | 1.26e-06 | 143 |
hsa05163210 | Esophagus | ESCC | Human cytomegalovirus infection | 148/4205 | 225/8465 | 5.73e-07 | 4.00e-06 | 2.05e-06 | 148 |
hsa046259 | Esophagus | ESCC | C-type lectin receptor signaling pathway | 73/4205 | 104/8465 | 1.57e-05 | 7.98e-05 | 4.09e-05 | 73 |
hsa0501728 | Esophagus | ESCC | Spinocerebellar ataxia | 94/4205 | 143/8465 | 6.77e-05 | 2.90e-04 | 1.48e-04 | 94 |
hsa0462122 | Esophagus | ESCC | NOD-like receptor signaling pathway | 116/4205 | 186/8465 | 2.90e-04 | 1.03e-03 | 5.30e-04 | 116 |
hsa0492816 | Esophagus | ESCC | Parathyroid hormone synthesis, secretion and action | 66/4205 | 106/8465 | 5.86e-03 | 1.47e-02 | 7.51e-03 | 66 |
hsa0492214 | Esophagus | ESCC | Glucagon signaling pathway | 64/4205 | 107/8465 | 2.18e-02 | 4.80e-02 | 2.46e-02 | 64 |
hsa041146 | Esophagus | ESCC | Oocyte meiosis | 77/4205 | 131/8465 | 2.19e-02 | 4.80e-02 | 2.46e-02 | 77 |
Page: 1 2 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ITPR1 | SNV | Missense_Mutation | novel | c.3497N>T | p.Tyr1166Phe | p.Y1166F | Q14643 | protein_coding | tolerated(0.58) | benign(0.433) | TCGA-DD-AACL-01 | Liver | liver hepatocellular carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ITPR1 | SNV | Missense_Mutation | novel | c.7394A>G | p.Asp2465Gly | p.D2465G | Q14643 | protein_coding | deleterious(0.01) | possibly_damaging(0.72) | TCGA-DD-AADG-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD |
ITPR1 | SNV | Missense_Mutation | c.4738C>A | p.Arg1580Ser | p.R1580S | Q14643 | protein_coding | tolerated(0.09) | benign(0.195) | TCGA-DD-AAW2-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
ITPR1 | SNV | Missense_Mutation | c.5368N>C | p.Cys1790Arg | p.C1790R | Q14643 | protein_coding | deleterious(0.03) | probably_damaging(0.985) | TCGA-G3-A3CK-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
ITPR1 | SNV | Missense_Mutation | c.1090N>T | p.Asp364Tyr | p.D364Y | Q14643 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-UB-A7MB-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Targeted Molecular therapy | sorafenib | PD | |
ITPR1 | SNV | Missense_Mutation | novel | c.4061N>A | p.Arg1354Gln | p.R1354Q | Q14643 | protein_coding | tolerated(0.52) | benign(0.011) | TCGA-ZS-A9CE-01 | Liver | liver hepatocellular carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
ITPR1 | deletion | Frame_Shift_Del | novel | c.874_878delNNNNN | p.Cys292GlyfsTer28 | p.C292Gfs*28 | Q14643 | protein_coding | TCGA-FV-A495-01 | Liver | liver hepatocellular carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
ITPR1 | SNV | Missense_Mutation | novel | c.7738G>T | p.Gly2580Trp | p.G2580W | Q14643 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-05-4396-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
ITPR1 | SNV | Missense_Mutation | novel | c.4780N>C | p.Ile1594Leu | p.I1594L | Q14643 | protein_coding | deleterious(0) | possibly_damaging(0.598) | TCGA-44-2668-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD |
ITPR1 | SNV | Missense_Mutation | novel | c.5753N>T | p.Lys1918Ile | p.K1918I | Q14643 | protein_coding | tolerated(0.14) | benign(0.313) | TCGA-44-7669-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | alimta | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
3708 | ITPR1 | ION CHANNEL, KINASE, DRUGGABLE GENOME, TRANSPORTER | antagonist | 135651544 | ||
3708 | ITPR1 | ION CHANNEL, KINASE, DRUGGABLE GENOME, TRANSPORTER | activator | 178101039 | ||
3708 | ITPR1 | ION CHANNEL, KINASE, DRUGGABLE GENOME, TRANSPORTER | activator | 135652731 | ||
3708 | ITPR1 | ION CHANNEL, KINASE, DRUGGABLE GENOME, TRANSPORTER | antagonist | 135652750 | ||
3708 | ITPR1 | ION CHANNEL, KINASE, DRUGGABLE GENOME, TRANSPORTER | activator | 178100946 | ||
3708 | ITPR1 | ION CHANNEL, KINASE, DRUGGABLE GENOME, TRANSPORTER | antagonist | 178101161 | ||
3708 | ITPR1 | ION CHANNEL, KINASE, DRUGGABLE GENOME, TRANSPORTER | activator | 178101040 | ||
3708 | ITPR1 | ION CHANNEL, KINASE, DRUGGABLE GENOME, TRANSPORTER | antagonist | 135652675 | CAFFEINE | |
3708 | ITPR1 | ION CHANNEL, KINASE, DRUGGABLE GENOME, TRANSPORTER | activator | 135651446 | ADENOSINE TRIPHOSPHATE | |
3708 | ITPR1 | ION CHANNEL, KINASE, DRUGGABLE GENOME, TRANSPORTER | Nitroprusside | NITROPRUSSIDE |
Page: 1 |